Regional Health Properties' Net Loss Widens Amid Revenue Surge, Delisting

TL;DR

**RHEPB's revenue jump is a mirage; ballooning expenses and a widening net loss make this a risky bet, especially after its NYSE American delisting.**

AI Summary

Regional Health Properties, Inc. (RHEPB) reported a significant increase in total revenues for the six months ended June 30, 2025, reaching $17.247 million, up from $8.451 million in the prior year, primarily driven by a surge in patient care revenues to $14.416 million from $4.834 million. Despite this revenue growth, the company's net loss widened to $2.711 million for the six months ended June 30, 2025, compared to a net loss of $1.668 million in the same period of 2024. This increased loss was largely due to a substantial rise in patient care expenses to $11.585 million from $4.283 million, and general and administrative expenses nearly doubling to $4.659 million from $2.860 million. The company also incurred a $303,000 loss on lease termination and a significant increase in credit loss expense to $470,000 from $65,000. Strategic changes include the delisting of its common stock and Series A Preferred Stock from NYSE American on June 11, 2025, with both now trading on the OTCQB under symbols RHEP and RHEPA, respectively. The company's total liabilities increased to $65.592 million as of June 30, 2025, from $63.384 million at December 31, 2024, further exacerbating its stockholders' deficit to $(5.454) million from $(2.919) million.

Why It Matters

For investors, the significant increase in net loss to $2.711 million despite a doubling of revenue signals underlying operational inefficiencies and rising costs, particularly in patient care and administrative overhead. The delisting from NYSE American to OTCQB on June 11, 2025, reduces liquidity and institutional investor interest, potentially impacting stock valuation and future capital raising efforts. Employees might face uncertainty given the company's widening deficit and operational challenges. Customers of the Healthcare Services segment could see potential impacts on service quality if financial pressures persist. In the broader market, this highlights the challenges faced by smaller healthcare real estate investment companies, especially those with direct healthcare service operations, in a competitive and cost-intensive environment.

Risk Assessment

Risk Level: high — The company's net loss widened to $2.711 million for the six months ended June 30, 2025, from $1.668 million in the prior year, indicating deteriorating profitability. Furthermore, the stockholders' deficit increased significantly to $(5.454) million as of June 30, 2025, from $(2.919) million at December 31, 2024, demonstrating a precarious financial position. The delisting from NYSE American to OTCQB on June 11, 2025, also signals reduced market confidence and liquidity.

Analyst Insight

Investors should exercise extreme caution and consider divesting, given the widening net loss, increasing stockholders' deficit, and the delisting from NYSE American. The significant increase in patient care expenses and general and administrative costs suggests fundamental operational issues that outweigh the revenue growth. Monitor future filings for any signs of improved cost control or a clear path to profitability.

Financial Highlights

debt To Equity

N/A

revenue

$17.247M

operating Margin

N/A

total Assets

$60.138M

total Debt

$49.725M

net Income

$(2.711)M

eps

N/A

gross Margin

N/A

cash Position

$0.401M

revenue Growth

+104.1%

Revenue Breakdown

Key Numbers

• $17.247M — Total Revenues (Increased from $8.451M for the six months ended June 30, 2024)
• $14.416M — Patient Care Revenues (Increased from $4.834M for the six months ended June 30, 2024)
• $(2.711)M — Net Loss (Widened from $(1.668)M for the six months ended June 30, 2024)
• $11.585M — Patient Care Expense (Increased from $4.283M for the six months ended June 30, 2024)
• $4.659M — General and Administrative Expense (Increased from $2.860M for the six months ended June 30, 2024)
• $303K — Loss on Lease Termination (New expense for the six months ended June 30, 2025)
• $470K — Credit Loss Expense (Increased from $65K for the six months ended June 30, 2024)
• $(5.454)M — Total Stockholders' Deficit (Worsened from $(2.919)M at December 31, 2024)
• 2,242,239 — Common Stock Shares Outstanding (As of August 12, 2025)
• $65.592M — Total Liabilities (Increased from $63.384M at December 31, 2024)

Key Players & Entities

• REGIONAL HEALTH PROPERTIES, INC. (company) — registrant
• NYSE American LLC (regulator) — exchange that delisted RHEPB
• U.S. Securities and Exchange Commission (regulator) — filing recipient
• OTCQB (company) — current trading market for RHEPB
• Meadowood (company) — healthcare facility operated by Regional Health
• Glenvue (company) — healthcare facility operated by Regional Health
• Mountain Trace (company) — healthcare facility where Regional Health recognizes patient care revenue
• U.S. Department of Health and Human Services Centers for Medicare and Medicaid Services (regulator) — source of patient care revenue
• FASB (regulator) — accounting standards body
• Bloomberg (company) — publisher

FAQ

Risk Factors

• Widening Net Loss and Stockholders' Deficit [high — financial]: The company reported a net loss of $2.711 million for the six months ended June 30, 2025, an increase from $1.668 million in the prior year. This has contributed to a widening stockholders' deficit to $(5.454) million from $(2.919) million.
• Increased Operating Expenses [high — operational]: Patient care expenses rose substantially to $11.585 million from $4.283 million, and general and administrative expenses nearly doubled to $4.659 million from $2.860 million. This indicates significant cost pressures impacting profitability.
• Increased Credit Loss Expense [medium — financial]: Credit loss expense increased significantly to $470,000 from $65,000, suggesting potential deterioration in the collectibility of receivables or increased risk in customer financial health.
• Loss on Lease Termination [low — operational]: The company incurred a $303,000 loss on lease termination, which is a new expense and negatively impacted the current period's results.
• Delisting from NYSE American [medium — market]: The company's common stock and Series A Preferred Stock were delisted from NYSE American and are now trading on the OTCQB. This may reduce liquidity and investor visibility.
• Increasing Total Liabilities [medium — financial]: Total liabilities increased to $65.592 million as of June 30, 2025, from $63.384 million at December 31, 2024, further straining the company's financial position.

Industry Context

The healthcare services industry, particularly segments involving patient care and facility management, is characterized by high operating costs, regulatory scrutiny, and sensitivity to reimbursement rates. Companies in this sector often face challenges in managing patient care expenses, administrative overhead, and credit risk associated with patient payments. Consolidation and shifts in service delivery models are ongoing trends.

Regulatory Implications

As a healthcare provider, RHEPB is subject to extensive regulations concerning patient care, billing, and data privacy (e.g., HIPAA). Changes in reimbursement policies from government programs like Medicare and Medicaid can significantly impact revenue. The delisting from NYSE American may also bring increased scrutiny from OTC market regulators.

What Investors Should Do

1. Monitor expense management closely.
2. Assess the impact of the OTCQB listing.
3. Evaluate the sustainability of revenue growth.
4. Review the company's debt structure and covenants.

Key Dates

• 2025-06-30: Six months ended June 30, 2025 financial results reported — Indicates significant revenue growth but also a widening net loss and increased expenses.
• 2025-06-11: Delisting from NYSE American — Common stock and Series A Preferred Stock moved to OTCQB, potentially impacting liquidity and investor perception.
• 2025-06-30: Consolidated Balance Sheet as of June 30, 2025 — Shows increased total liabilities and a worsened stockholders' deficit compared to year-end 2024.

Glossary

Stockholders' Deficit

A situation where a company's total liabilities exceed its total assets, resulting in a negative equity value. (RHEPB has a significant and growing stockholders' deficit, indicating a precarious financial position.)

OTC QB

A quotation service for over-the-counter (OTC) stocks, operated by OTC Markets Group. It is a market for smaller companies that are not listed on major exchanges. (RHEPB's securities now trade on this market after being delisted from NYSE American.)

Credit Loss Expense

An expense recognized by a company for potential losses on accounts receivable or other financial assets that are unlikely to be collected. (A substantial increase in this expense suggests potential issues with customer payments or financial health.)

Right-of-use operating lease assets

An asset recognized under accounting standards (ASC 842) representing a lessee's right to use an identified asset for a specified period. (This is a component of the company's assets related to its operating leases.)

Year-Over-Year Comparison

For the six months ended June 30, 2025, Regional Health Properties, Inc. experienced a dramatic increase in total revenues to $17.247 million, more than double the $8.451 million reported in the prior year, primarily driven by patient care revenues. However, this top-line growth was overshadowed by a significant widening of the net loss to $2.711 million from $1.668 million. Operating expenses, particularly patient care and general and administrative costs, rose disproportionately, leading to a substantial increase in the net loss. The company's financial position also weakened, with total liabilities increasing and the stockholders' deficit worsening.

Filing Documents

• rhe-20250630.htm (10-Q) — 3024KB
• rhe-ex2_3.htm (EX-2.3) — 320KB
• rhe-ex31_1.htm (EX-31.1) — 15KB
• rhe-ex31_2.htm (EX-31.2) — 15KB
• rhe-ex32_1.htm (EX-32.1) — 8KB
• rhe-ex32_2.htm (EX-32.2) — 8KB
• 0000950170-25-108917.txt ( ) — 13955KB
• rhe-20250630.xsd (EX-101.SCH) — 1907KB
• rhe-20250630_htm.xml (XML) — 2950KB

Financial Statements (unaudited)

Financial Statements (unaudited) 4 Consolidated Balance Sheets as of June 30, 2025 and December 31, 2024 4 Consolidated Statements of Operations for the three and six months ended June 30, 2025 and 2024 6 Consolidated Statements of Stockholders' Deficit for the three and six months ended June 30, 2025 and 2024 7 Consolidated Statements of Cash Flows for the six months ended June 30, 2025 and 2024 8

Notes to Consolidated Financial Statements

Notes to Consolidated Financial Statements 10 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 28 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 37 Item 4.

Controls and Procedures

Controls and Procedures 37 Part II. OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 37 Item 1A.

Risk Factors

Risk Factors 37 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 38 Item 3. Defaults upon Senior Securities 38 Item 4. Mine Safety Disclosures 38 Item 5. Other Information 38 Item 6. Exhibits 38

Financial Information

Part I. Financial Information

Financial Statements

Item 1. Financial Statements REGIONAL HEALTH PROPERTIES, INC. AND SUBSIDIARIES CONSOLIDATED B ALANCE SHEETS (Amounts in 000's) June 30, 2025 December 31, 2024 (Unaudited) ASSETS Property and equipment, net $ 33,015 $ 33,489 Asset held for sale, net 10,372 10,334 Cash 401 582 Restricted cash 2,808 2,890 Accounts receivable, net of allowances of $ 470 and $ 141 4,367 3,362 Prepaid expenses and other 692 633 Notes receivable 369 369 Intangible assets - bed licenses 2,471 2,471 Intangible assets - lease rights, net 60 69 Right-of-use operating lease assets 1,929 2,154 Goodwill 1,585 1,585 Straight-line rent receivable 2,069 2,527 Total assets $ 60,138 $ 60,465 LIABILITIES AND EQUITY (DEFICIT) Senior debt, net $ 34,238 $ 34,829 Debt related to asset held for sale, net 8,012 8,121 Bonds, net 5,695 5,851 Other debt, net 975 919 Accounts payable 7,082 3,695 Accrued expenses 5,976 5,414 Operating lease obligation 2,220 2,472 Other liabilities 1,394 2,082 Total liabilities 65,592 63,384 Commitments and contingencies (Note 12) Stockholders' deficit: Common stock and additional paid-in capital, no par value; 55,000 shares authorized; 2,253 shares issued and 2,242 shares outstanding at June 30, 2025; and 1,890 shares issued and 1,879 shares outstanding at December 31, 2024 63,952 63,173 Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A and Series B); shares issued and outstanding designated as follows: Preferred stock, Series A, no par value; 559 shares authorized, issued and outstanding at June 30, 2025 and December 31, 2024, with a redemption amount $ 426 at June 30, 2025 and December 31, 2024 426 426 Preferred stock, Series B, no par value; 2,812 shares authorized; 2,252 shares issued and outstanding at June 30, 2025 and December 31, 2024, with a redempt

View Full Filing

View this 10-Q filing on SEC EDGAR